HIV positive patient treated with ixekizumab

Clin Ter. 2022 May 25;173(3):195-197. doi: 10.7417/CT.2022.2416.

Abstract

Psoriasis is a immune-mediated, chronic, inflammatory skin dis-ease. In HIV positive (HIV+) patients we usually observe more serious clinical features and recalcitrant course. Furthermore, therapeutic man-agement of HIV+ patient is complex and requires collaboration with the infectious disease specialist. We report the case of a patient affected by severe psoriasis who contracted HIV infection during biological therapy and, subsequently, succesfully treated with ixekizumab.

Keywords: HIV; Psoriasis; psoriasis treatment.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use
  • HIV Infections* / complications
  • HIV Infections* / drug therapy
  • Humans
  • Male
  • Psoriasis* / complications
  • Psoriasis* / drug therapy
  • Severity of Illness Index
  • Skin
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal, Humanized
  • ixekizumab